Cargando…

β-Amyloid(1-42), HIV-1(Ba-L) (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A

Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. Withania somnifera (WS) also known as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurapati, Kesava Rao Venkata, Samikkannu, Thangavel, Atluri, Venkata Subba Rao, Kaftanovskaya, Elena, Yndart, Adriana, Nair, Madhavan P. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240587/ https://www.ncbi.nlm.nih.gov/pubmed/25415340 http://dx.doi.org/10.1371/journal.pone.0112818

Ejemplares similares

Ashwagandha (Withania somnifera) Reverses β-Amyloid(1-42) Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)
por: Kurapati, Kesava Rao Venkata, et al.
Publicado: (2013)

Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2015)

Withasomniferol D, a New Anti-Adipogenic Withanolide from the Roots of Ashwagandha (Withania somnifera)
por: Lee, Bum Soo, et al.
Publicado: (2021)

Investigating 11 Withanosides and Withanolides by UHPLC–PDA and Mass Fragmentation Studies from Ashwagandha (Withania somnifera)
por: Girme, Aboli, et al.
Publicado: (2020)

Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2015)

Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
por: Kurapati, Kesava Rao V., et al.
Publicado: (2016)

Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2014)

Transcription factor repertoire in Ashwagandha (Withania somnifera) through analytics of transcriptomic resources: Insights into regulation of development and withanolide metabolism
por: Tripathi, Sandhya, et al.
Publicado: (2017)

Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice
por: Dey, Amitabha, et al.
Publicado: (2018)

Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)

Endophytes of Withania somnifera modulate in planta content and the site of withanolide biosynthesis
por: Pandey, Shiv S., et al.
Publicado: (2018)

Influence of lunar cycles on growth of Ashwagandha (Withania somnifera [L.] Dunal)
por: Tavhare, Swagata D., et al.
Publicado: (2015)

Ashwagandha (Withania somnifera) supercritical CO(2) extract derived withanolides mitigates Bisphenol A induced mitochondrial toxicity in HepG2 cells
por: Vidyashankar, Satyakumar, et al.
Publicado: (2014)

Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2016)

Effect of Cocaine on HIV Infection and Inflammasome Gene Expression Profile in HIV Infected Macrophages
por: Atluri, Venkata Subba Rao, et al.
Publicado: (2016)

Identification of anti-adipogenic withanolides from the roots of Indian ginseng (Withania somnifera)
por: Lee, Seoung Rak, et al.
Publicado: (2022)

Antitumor Potential of Withanolide Glycosides from Ashwagandha (Withania somnifera) on Apoptosis of Human Hepatocellular Carcinoma Cells and Tube Formation in Human Umbilical Vein Endothelial Cells
por: Lee, Dahae, et al.
Publicado: (2022)

Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction
por: Mamidi, Prasad, et al.
Publicado: (2011)

P01.44. In vivo immune modulating effects of Ashwagandha (Withania somnifera)
por: Erlandsen, A, et al.
Publicado: (2012)

An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha)
por: Bashir, Arsalan, et al.
Publicado: (2023)

Sub-acute toxicity of Ashwagandha (Withania somnifera) root extract in wistar rats
por: Langade, Deepak, et al.
Publicado: (2023)

Comparative interactions of withanolides and sterols with two members of sterol glycosyltransferases from Withania somnifera
por: Pandey, Vibha, et al.
Publicado: (2015)

Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system
por: Devkar, Santosh T., et al.
Publicado: (2015)

Structural Characterization of Withanolide Glycosides from the Roots of Withania somnifera and Their Potential Biological Activities
por: Ha, Ji Won, et al.
Publicado: (2022)

Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers
por: Raut, Ashwinikumar A., et al.
Publicado: (2012)

Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction
por: Kaushik, Mahesh K., et al.
Publicado: (2017)

Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis
por: Bonilla, Diego A., et al.
Publicado: (2021)

Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis
por: Cheah, Kae Ling, et al.
Publicado: (2021)

Ashwagandha (Withania somnifera)—Current Research on the Health-Promoting Activities: A Narrative Review
por: Mikulska, Paulina, et al.
Publicado: (2023)

Silencing of sterol glycosyltransferases modulates the withanolide biosynthesis and leads to compromised basal immunity of Withania somnifera
por: Singh, Gaurav, et al.
Publicado: (2016)

Optimization of Elicitation Conditions to Enhance the Production of Potent Metabolite Withanolide from Withania somnifera (L.)
por: Singh, Manali, et al.
Publicado: (2022)

High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis
por: Alam, Nadia, et al.
Publicado: (2011)

Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults
por: Choudhary, Bakhtiar, et al.
Publicado: (2015)

Effects of Ashwagandha (Withania somnifera) on VO(2max): A Systematic Review and Meta-Analysis
por: Pérez-Gómez, Jorge, et al.
Publicado: (2020)

Effects of Withania somnifera (Ashwagandha) on Stress and the Stress-Related Neuropsychiatric Disorders Anxiety, Depression, and Insomnia
por: Speers, Alex B., et al.
Publicado: (2021)

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
por: Dar, Nawab John, et al.
Publicado: (2023)

Ninety-day repeated dose toxicity of Ashwagandha (Withania somnifera) root extract in Wistar rats
por: Kalaivani, P., et al.
Publicado: (2023)

HIV-1 gp120 and morphine induced oxidative stress: role in cell cycle regulation
por: Samikkannu, Thangavel, et al.
Publicado: (2015)

Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate
por: Bhat, Javeed Ahmad, et al.
Publicado: (2022)

A Study of Efficacy and Safety of Ashwagandha (Withania somnifera) Lotion on Facial Skin in Photoaged Healthy Adults
por: Narra, Keerthi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6u863u3d67cf6o79fr3krfib1b